Skip to content

Essity

Swedish multinational hygiene and health company supplying personal care, tissue, professional hygiene, and medical products.

Last updated November 4, 2026

AI crawler reads

148requests

7AI
  • OpenAI106
  • Perplexity15
  • Amazon12
  • Shape10
  • Anthropic3
  • +22
Profile
118
Controversies
16
JSON · MD
0
First read
Oct 29, 2026
Latest read
Nov 17, 2026

From this site's server log

Overview

Essity is a Swedish multinational hygiene and health company headquartered in Stockholm. It was created in 2017 when the hygiene and health activities of Svenska Cellulosa Aktiebolaget, commonly known as SCA, were separated from the parent group's forestry operations and listed as an independent company on Nasdaq Stockholm. The name Essity combines the ideas of essentials and necessity, reflecting the company's focus on products used in everyday hygiene, health care, and professional environments. The company operates across consumer and business-to-business categories. Its personal-care portfolio includes baby diapers, feminine-care products, and incontinence products. Its tissue business serves households, workplaces, hospitality venues, and public institutions through consumer tissue and professional hygiene solutions. Its medical-care activities include compression therapy, wound care, orthopaedics, casting products, and related medical supplies. Major brands associated with Essity include TENA, Tork, Libero, Libresse, JOBST, Leukoplast, Lotus, Tempo, Zewa, and Saba, although brand availability varies by country. Essity's modern business developed from SCA's long expansion beyond forestry. SCA acquired Mölnlycke in 1975, adding a significant European disposable-hygiene business, and later built scale through acquisitions in tissue, packaging, medical care, and regional consumer products. Important transactions included PWA in 1995, Wisconsin Tissue in 2001, Carter Holt Harvey's tissue and hygiene businesses in 2004, Procter & Gamble's European tissue business in 2007, Georgia-Pacific's European tissue operations in 2012, and BSN Medical in 2017. SCA also became a major shareholder in the Chinese tissue company Vinda before the Essity separation. Essity serves consumers, retailers, health-care providers, employers, and institutional customers. Its brands are positioned around everyday utility, personal dignity, health outcomes, convenience, professional hygiene, and category expertise. TENA focuses on continence care, Tork on professional hygiene, Libero on baby care, Libresse on feminine care, and JOBST and related medical brands on compression and clinical care. The company competes with large consumer-goods, tissue, medical-supply, and regional manufacturers including Procter & Gamble, Kimberly-Clark, Unilever, Georgia-Pacific, 3M, Ontex, Unicharm, Sofidel, CMPC, and Santher. Essity has also made sustainability a prominent part of its corporate positioning. Its initiatives include science-based emissions-reduction targets, participation in sustainability indexes, engagement with the Ellen MacArthur Foundation's New Plastics Economy initiative, and packaging objectives involving renewable or recycled materials. At the same time, environmental groups have criticized the company's forestry sourcing and alleged impacts on old-growth forests, biodiversity, climate, and Indigenous communities. Labor relations and market-exit decisions have also attracted public attention. In 2022, Essity announced legal action connected with an industrial dispute at its Kawerau paper mill in New Zealand, and in 2023 it announced its withdrawal from the Russian market. Essity is an active, publicly traded company with a global operating footprint. Reference material describes approximately 36,000 employees and 2023 net sales of approximately EUR 13 billion. The company remains organized around consumer goods, professional hygiene, and health-care solutions rather than a single product category.

History

Essity's history is rooted in Svenska Cellulosa Aktiebolaget, or SCA, which was founded in 1929 as a Swedish forestry company. SCA gradually expanded into pulp, paper, tissue, and hygiene products. A major early step was its 1975 acquisition of Mölnlycke, a Western European producer of disposable hygiene products. This transaction established a platform for the health and hygiene activities that would eventually become Essity. SCA continued to broaden its tissue and consumer-products operations through acquisitions. In 1995 it acquired the German paper and packaging company PWA, Papierwerke Waldhof-Aschaffenburg. In 2001 it bought Wisconsin Tissue from Georgia-Pacific Tissue, strengthening its North American tissue presence. In 2004 SCA acquired tissue and hygiene businesses from Carter Holt Harvey, which had been owned by International Paper. In 2007 it purchased Procter & Gamble's European tissue business for approximately EUR 512 million and acquired its first minority stake in the Asian tissue company Vinda. SCA also expanded in Latin America and Asia. In 2011 it acquired Brazilian company Pro Descart, including the Biofral and Drybaby brands, and subsequently invested in a plant at Jarinu in São Paulo state to support brands including TENA and Tork. In 2012 it completed the acquisition of Georgia-Pacific's European tissue operations, including the Lotus brand, for approximately EUR 1.32 billion. In 2013 SCA became Vinda's majority shareholder. By 2015, SCA was described as the world's largest tissue-paper producer. The group then began a structural separation of its forestry and hygiene businesses. In 2015 SCA announced that the two activities would be organized as separate divisions. In August 2016 it announced its intention to split into two separately listed companies. The hygiene and health company also expanded its medical-care platform through the acquisition of BSN Medical, announced in December 2016 and completed around the creation of Essity. BSN Medical specialized in compression therapy, wound care, and orthopaedics and brought brands including JOBST, Leukoplast, Cutimed, Delta Cast, and Actimove. The reported purchase price was approximately EUR 2.74 billion. Essity was separated from SCA and listed on Nasdaq Stockholm on June 15, 2017. As an independent company, it combined consumer tissue, professional hygiene, personal care, and medical-care operations under one corporate identity. Its brands remained locally adapted in many markets, with names such as TENA, Tork, Libero, Libresse, Lotus, Tempo, Zewa, and Saba operating across different geographic and category contexts. After the separation, Essity continued to present itself as a global hygiene and health specialist. Its activities span retail products, professional systems, and products sold through health-care channels. The company has emphasized climate targets, renewable and recycled packaging, and participation in international sustainability initiatives. Its environmental record has nevertheless been contested by Greenpeace, while a 2022 New Zealand labor dispute generated litigation-related criticism. In 2023 Essity announced its exit from Russia. Governance changes included the appointment of Jan Gurander as chairman in 2024 and Ulrika Kolsrud as president and CEO in 2025. Reference material reports that Essity operated in approximately 150 countries, served more than one billion people, employed approximately 36,000 people, and recorded approximately EUR 13 billion in net sales in 2023.

  • 2023

    Russian market exit

    [1]

    Essity announces its intention to leave the Russian market.

  • 2018

    Science-based emissions target

    [1]

    Essity's emissions-reduction target is approved as aligned with climate science.

  • 2017

    BSN Medical acquisition and Essity listing

    [1]

    SCA adds BSN Medical's medical-care portfolio, and Essity is listed independently in Stockholm on June 15.

  • 2016

    SCA announces corporate split

    [1]

    SCA announces its intention to separate forestry and hygiene activities into two listed companies.

  • 2013

    SCA becomes majority shareholder in Vinda

    [1]

    SCA becomes Vinda's majority shareholder, strengthening its Asian tissue presence.

  • 2012

    Georgia-Pacific European tissue acquisition

    [1]

    SCA completes the acquisition of Georgia-Pacific's European tissue operations, including Lotus.

  • 2007

    European tissue expansion

    [1]

    SCA buys Procter & Gamble's European tissue business and takes its first minority stake in Vinda.

  • 2004

    Carter Holt Harvey tissue and hygiene acquisition

    [1]

    SCA acquires tissue and hygiene businesses from Carter Holt Harvey.

  • 2001

    Wisconsin Tissue acquisition

    [1]

    SCA acquires Wisconsin Tissue from Georgia-Pacific Tissue.

  • 1995

    PWA acquisition

    [1]

    SCA acquires German paper and packaging company PWA.

Products and positioning

A global hygiene and health company focused on essential everyday products, professional hygiene systems, and specialized medical-care solutions.

  • Incontinence care

    TENA

    TENA is Essity's principal continence-care brand, offering absorbent products and related solutions for adults experiencing bladder or bowel leakage. The brand serves consumers, caregivers, and institutional health-care settings.

  • Professional hygiene

    Tork

    Tork provides professional tissue, wiping, soap, dispensing, and hygiene-management solutions for workplaces, hospitality, health-care facilities, and public environments.

  • Baby care

    Libero

    Libero is a baby-care brand associated primarily with diapers and related products. Its market presence is particularly strong in Nordic and European markets.

  • Feminine care

    Libresse

    Libresse offers feminine-care products, including menstrual protection, and is marketed through regionally adapted brand identities and communications.

  • Compression therapy

    JOBST

    JOBST is a medical brand acquired through BSN Medical and is associated with compression garments and products used in the management of venous and lymphatic conditions.

  • Wound care

    Leukoplast

    Leukoplast is part of Essity's medical-care portfolio and provides adhesive products and related solutions for wound care and clinical use.

  • Tissue

    Consumer tissue portfolio

    Essity's consumer tissue portfolio includes toilet tissue, facial tissue, household towels, and related paper products sold under brands such as Lotus, Tempo, Zewa, Cushelle, Plenty, and regional labels.

Controversies

  • 2022

    Kawerau mill labor dispute

    During a pay dispute involving 145 workers at Essity's Kawerau paper mill in New Zealand, the company announced an intention to sue locked-out striking workers over an alleged strike beginning approximately one hour earlier than stated.

  • Greenpeace criticism of forestry sourcing

    Greenpeace accused Essity and its supplier SCA of unsustainable forestry practices, including alleged clearing of old-growth forests and damage to threatened species, climate stability, and Indigenous communities.

Read more

Brand decisions

  • 2026

    Essity agrees to acquire Kenvue's feminine care business in BrazilM&A

    Background

    Essity has entered into an agreement to acquire Kenvue's feminine care business in Brazil, including the Carefree, Sempre Livre and o.b. brands, for USD 284m on a cash and debt-free basis. The transaction is subject to regulatory approval in Brazil and other customary closing conditions, including completion of the Kimberly-Clark and Kenvue transaction, and is expected to close in the second quarter of 2027.

  • 2023

    Essity announces agreement to divest Russian operationsM&A

    Background

    Essity announced that it had signed an agreement with a buyer to divest its operations in Russia; the transaction was expected to be finalized during the second quarter of 2023.

  • 2022

    Essity announces acquisition of ModibodiM&A

    Background

    Essity announced that it was acquiring Australian leakproof apparel company Modibodi for AUD 140 million. The transaction was expected to be finalized in the second half of 2022.

  • 2022

    Essity acquires Legacy ConvertingM&A

    Background

    Essity acquired US professional wiping and cleaning company Legacy Converting, Inc. for USD 40 million, with a potential additional earnout of USD 10 million.

  • 2021

    Essity acquires HydroferaM&A

    Background

    Essity acquired Hydrofera, a US company offering technology and products in advanced wound care, for USD 116 million with a potential additional earnout of USD 15 million.

  • 2021

    Essity completes acquisition of additional Familia sharesM&A

    Background

    Essity finalized its acquisition of 45.8% of the shares in Productos Familia S.A., bringing its ownership of Familia to 95.8%.

  • 2021

    Essity acquires remaining Asaleo Care sharesM&A

    Background

    Essity was reported to have acquired the Asaleo Care shares it did not already own through a scheme of arrangement valued at $788 million. The article also describes the acquisition as proposed and says Essity had reached an important stage in acquiring the outstanding shares.

  • 2020

    Essity agrees to acquire 75% of ABIGO MedicalM&A

    Background

    Essity signed an agreement to acquire 75% of Swedish medical solutions company ABIGO Medical AB. The transaction is subject to customary regulatory approvals, with closing expected in the second quarter of 2020.

Recent events

  • Essity agrees to acquire Kenvue's feminine care business in Brazil[2]

    Reported

    Essity has entered into an agreement to acquire Kenvue's feminine care business in Brazil, including the Carefree, Sempre Livre and o.b. brands, for USD 284m on a cash and debt-free basis. The transaction is subject to regulatory approval in Brazil and other customary closing conditions, including completion of the Kimberly-Clark and Kenvue transaction, and is expected to close in the second quarter of 2027.

  • Essity launches Caressa caregiver platform[10]

    Reported

    Essity launched Caressa, a subscription-based digital platform to help family members coordinate care tasks, medications and appointments. It was available for download in Sweden and the UK.

  • Unilever expands Tesco hygiene donations campaign with three suppliers[11]

    Reported

    Unilever and In Kind Direct expanded their donations campaign at Tesco by partnering with Kimberly-Clark, Essity and Haleon. The four manufacturers would donate one product for every two selected products purchased through Tesco until 3 October.

  • Essity announces agreement to divest Russian operations[3]

    Reported

    Essity announced that it had signed an agreement with a buyer to divest its operations in Russia; the transaction was expected to be finalized during the second quarter of 2023.

  • Unconfirmed

    Russian authorities approve Essity transaction[3]

    Reported

    The Russian authorities approved the transaction for Essity's divestment of its Russian operations; the source does not state when the approval occurred.

  • Essity announces acquisition of Modibodi[4]

    Reported

    Essity announced that it was acquiring Australian leakproof apparel company Modibodi for AUD 140 million. The transaction was expected to be finalized in the second half of 2022.

  • Essity acquires Legacy Converting[5]

    Reported

    Essity acquired US professional wiping and cleaning company Legacy Converting, Inc. for USD 40 million, with a potential additional earnout of USD 10 million.

  • Essity announces price increases[12]

    Reported

    Essity announced price increases across all product categories and markets, with timing and degree to be managed locally. The company cited higher raw-material, energy and distribution costs.

  • Unconfirmed

    Essity acquires Hydrofera[6]

    Reported

    Essity acquired Hydrofera, a US company offering technology and products in advanced wound care, for USD 116 million with a potential additional earnout of USD 15 million.

  • Essity starts green hydrogen pilot for tissue production[13]

    Reported

    Essity launched a pilot at its Mainz-Kostheim production facility in Germany to replace natural gas progressively with green hydrogen in tissue production.

Read more(16)

Sources18 sources

Cite this profile: Cite the canonical profile. /brandpedia/essity · Editorial policy · How profiles are compiled